Market closed

Eli Lilly/$LLY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Ticker

$LLY

Trading on

NYSE

Industry

Pharmaceuticals

Employees

43,000

Eli Lilly Metrics

BasicAdvanced
$750B
Market cap
90.00
P/E ratio
$9.25
EPS
0.43
Beta
$5.03
Dividend rate
0.62%
Dividend yield
$750B
0.43
$972.53
$561.65
3.5M
$5.03
1.273
0.63
203.322
218.081
54.12%
21.46%
13.95%
65.32%
90.002
18.349
52.6
387.26
-429.823
0.60%
0.62%
27.41%
67.52%
13.76%
12.19%
15.20%

What the Analysts think about Eli Lilly

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Eli Lilly stock.

Eli Lilly Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Eli Lilly Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LLY

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Nov
15
Eli Lilly
Dividend·Ex-dividend
Dec
10
Eli Lilly
Dividend·Payment
$1.30
Per share

FAQs

What’s the current market cap for Eli Lilly stock?

Eli Lilly (LLY) has a market cap of $750B as of November 13, 2024.

What is the P/E ratio for Eli Lilly stock?

The price to earnings (P/E) ratio for Eli Lilly (LLY) stock is 90 as of November 13, 2024.

Does Eli Lilly stock pay dividends?

Yes, the Eli Lilly (LLY) stock pays dividends to shareholders. As of November 13, 2024, the dividend rate is $5.03 and the yield is 0.62%. Eli Lilly has a payout ratio of 54.12% on a trailing twelve-month basis.

When is the next Eli Lilly dividend payment date?

The next Eli Lilly (LLY) dividend payment is scheduled for December 10, 2024.

What is the beta indicator for Eli Lilly?

Eli Lilly (LLY) has a beta rating of 0.43. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.